@article{69adb636b91f427e9130037569ba8d32,
title = "Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)",
author = "Bettinger, {Julie A.} and Paul Liberator and Halperin, {Scott A.} and Wendy Vaudry and Manish Sadarangani and Li Hao and Nathaniel Lambert and Jansen, {Kathrin U.} and Anderson, {Annaliesa S.} and Raymond Tsang",
note = "Funding Information: MS: MS is supported via salary awards from the BC Children{\textquoteright}s Hospital Foundation and the Canadian Child Health Clinician Scientist Program MS has been an investigator on studies funded by Merck, VBI Vaccines and GSK. All funds have been paid to his institute, and he has not received any personal payments. Funding Information: We gratefully acknowledge the expert assistance provided by the IMPACT Monitor Liaisons (Heather Samson and Annick Audet), the IMPACT nurse monitors and staff of the IMPACT data center (Kim Marty, Wenli Zhang, Suzanne Liu and Jennifer Mark), the staff of the National Microbiology Laboratory's DNA Core Facility for providing primers and help with DNA sequencing and our public health and infectious disease colleagues. We also thank Lubomira Andrew, Dennis Law, Jianwei Zhou, and Saul Deng for technical assistance. This study made use of the Neisseria MLST website (http://pubmlst.org /neisseria/) developed by Keith Jolley and Man-Suen Chan and sited at the University of Oxford, UK. The development of this site has been funded by the Wellcome Trust and European Union. JAB: contributed substantially to conception and design and acquisition of data, conducted the analysis and interpretation of data, AND drafted and revised the article, AND gave final approval of the version to be published, AND agreed to act as guarantor of the work (ensuring that questions related to any part of the work are appropriately investigated and resolved). SAH, WV, RT, PL, MS, ASA: contributed substantially to conception and design, acquisition and interpretation of data, AND revised the article critically for important intellectual content AND gave final approval of the version to be published, AND agreed to act as guarantor of the work (ensuring that questions related to any part of the work are appropriately investigated and resolved). LH, NL, KUJ: contributed substantially to acquisition of data AND revised the article critically for important intellectual content AND gave final approval of the version to be published, AND agreed to act as guarantor of the work (ensuring that questions related to any part of the work are appropriately investigated and resolved). Funding Information: We gratefully acknowledge the expert assistance provided by the IMPACT Monitor Liaisons (Heather Samson and Annick Audet), the IMPACT nurse monitors and staff of the IMPACT data center (Kim Marty, Wenli Zhang, Suzanne Liu and Jennifer Mark), the staff of the National Microbiology Laboratory{\textquoteright}s DNA Core Facility for providing primers and help with DNA sequencing and our public health and infectious disease colleagues. We also thank Lubomira Andrew, Dennis Law, Jianwei Zhou, and Saul Deng for technical assistance. This study made use of the Neisseria MLST website ( http://pubmlst.org /neisseria/ ) developed by Keith Jolley and Man-Suen Chan and sited at the University of Oxford , UK. The development of this site has been funded by the Wellcome Trust and European Union . Funding Information: The Canadian Immunization Monitoring Program, Active (IMPACT) is a national surveillance initiative managed by the Canadian Paediatric Society and conducted by the IMPACT network of pediatric investigators. IMPACT meningococcal surveillance was supported by a grant from Sanofi-Pasteur (2002–2011) and Novartis Vaccines & Diagnostics (2012). The additional typing and laboratory testing performed in this study was supported by a grant from Pfizer. Publisher Copyright: {\textcopyright} 2020 The Authors",
year = "2020",
month = feb,
day = "18",
doi = "10.1016/j.vaccine.2019.12.051",
language = "English",
volume = "38",
pages = "2026--2033",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "8",
}